Navigation Links
Astellas to Present at J.P. Morgan Healthcare Conference

NORTHBROOK, Ill., Jan. 7, 2014 /PRNewswire/ -- Astellas US LLC today announced that the Company's global President and CEO Yoshihiko Hatanaka will present at the 32nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2014 in San Francisco, Calif. The presentation will take place at the Westin St. Francis in the Colonial Room from 3:00 p.m. to 3:25 p.m. PST.

About Astellas

Astellas US LLC, located in Northbrook, Illinois is an affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. For more information on Astellas, please visit our website at or follow us on Twitter at @AstellasUS.

Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Astellas and Vical Announce Initiation of Phase 2 Trial of ASP0113, a Cytomegalovirus Vaccine, in Solid Organ Transplant Recipients
2. FDA Grants Astellas Qualified Infectious Disease Product Designation for Isavuconazole for the Treatment of Invasive Aspergillosis
3. La doctora Elizabeth H. Blackburn, Premio Nobel, se une al panel del ASTELLAS INNOVATION DEBATE 2013
4. Astellas US Appoints Senior Vice President, Chief Communications Officer
5. Astellas Employees to Change Tomorrow through Annual Day of Service
6. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
8. Astellas Appoints New Senior Vice President of Global Oncology Development
9. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
10. Molly Fletcher to Speak at Astellas Presents Executive Womens Day at the AT&T National
11. Astellas Signs Distribution Agreement With Tecnofarma For Enzalutamide In Latin America
Post Your Comments:
(Date:11/27/2015)... Ein neuer Kombinationsansatz vereint ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... --> Ein neuer Kombinationsansatz vereint Immuntherapie ... Clinical Cancer Research vom 6. November ... vom 6. November 2015 berichtet. --> ...
(Date:11/26/2015)... Un nuevo enfoque combina la ... cáncer avanzado.   --> Un nuevo ... Bremachlorin para el cáncer avanzado.   --> ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... --> Clinical Cancer Research . --> ...
(Date:11/26/2015)... 26, 2015 Research and Markets ( ) ... Pacemaker Market Outlook to 2019 - Rise in Cardiac Disorders ... report to their offering. Boston ... Boston scientific and others. --> ... Biotronik, Boston scientific and others. ...
Breaking Medicine Technology:
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss ... to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy followed ...
(Date:11/27/2015)... ... November 27, 2015 , ... The ... of USA Today in Atlanta, Dallas, New York, Minneapolis, South Florida, with a ... component is distributed nationally, through a vast social media strategy and across a ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... Microsoft Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end ... Microsoft Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership ...
(Date:11/27/2015)... ... 2015 , ... CBD College is proud to announce that on ... accreditation to its Diagnostic Medical Sonography program. CBD College is honored to join this ... colleges and universities in the state of California make the cut. CBD College is ...
(Date:11/27/2015)... ... ... Indosoft Inc., developer and distributor of the world-class Asterisk ... Term Support) into its Q-Suite 5.10 product line. , Making the change to ... of Asterisk that will receive not only security fixes, but feature and bug ...
Breaking Medicine News(10 mins):